Cardiology
News
New hypertension performance measures boost 130/80 mm Hg target
PHILADELPHIA – Hypertension performance and quality measures from the AHA and ACC provide a guide for implementing the 2017 hypertension guideline...
News
Farxiga granted Priority Review for treatment of adults with HFrEF
The Food and Drug Administration is reviewing dapagliflozin for reducing the risk of cardiovascular death or worsening of heart failure in adults...
News
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.
News
New ASH guideline: VTE prophylaxis after major surgery
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the...
News
Cardiac arrhythmia heightens mortality risk during epilepsy hospitalizations
BALTIMORE – A secondary diagnosis of apnea is not independently associated with increased odds of death, however.
News
Genetic test stratified AFib patients with low CHA2DS2-VASc scores
A 32-locus genetic test classified AFib patients with low CHA2DS2-VASc scores into high– and low–stroke-risk subgroups.
News
New heart failure trial data presage guideline revisions
PHILADELPHIA –
News
Aspirin plus a DOAC may do more harm than good in some
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication...
News
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
News
Large population-based study underscores link between gout, CVD event risk
ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New...